Individuals with compromised immunity and persistent COVID-19 infections can harbor drug-resistant variants of the SARS-CoV-2 virus, which have the potential to spread to the general population, ...
The following is a summary of “Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study,” published in the September 2024 issue of ...
After severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, prevalent metformin use is associated with a slightly lower incidence of death or postacute sequalae of SARS-CoV-2 (PASC).